Benjamin T. Dake, SEE REMARKS at Aerovate Therapeutics, Inc. (AVTE), sold 11,410 shares at $21.08 ($241K) on 2022-10-18, disclosed to the SEC on 2022-10-20.
Open-market sale of $241k AVTE by SEE REMARKS. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.08 | 5,705 | $120K | 50.0% |
| 2 | $21.08 | 5,705 | $120K | 50.0% |
| Total | $21.08 avg | 11,410 | $241K | 100% |
| Filing → |
| AVTE | SELL | 2024-03-28 | $619K | — | Filing → |
| AVTE | SELL | 2024-03-27 | $192K | — | Filing → |
| AVTE | SELL | 2024-03-20 | $1.8M | — | Filing → |